Shampoo Dermatological Pomegranate
Dermatological shampoo based on pomegranate extracts specifically developed to be used in dogs with sensitive skin or skin problems such as atopic dermatitis or other allergic processes that require frequent washing.
Its main active ingredient is pomegranate extract formulated with a base rich in vitamin A (retinol), Aloe vera extract and other medicinal plants such as marigold, rosemary and wormwood that provide its moisturizing, soothing and healing characteristics. It should be noted the protective effect of the pomegranate against solar radiation, which allows to enhance the brightness and health of the hair.
It is recommended to use it frequently to improve the quality of the hair and the skin.
Polyphenols found in pomegranate (punicalaginas) have been shown to inhibit the activity of inflammatory cells by preventing the release of cellular mediators that cause clinical conditions such as atopic dermatitis or other allergies.
In addition, pomegranate has a high antioxidant power, almost three times greater than green tea or wine, so it is able to accelerate the recovery of damaged skin, accelerating its healing. In addition, it is now well proven to neutralize the harmful effects of UVA rays and improve hair condition.
Presentations: 500ml and 5l.
(*) To pay with PayPal, Contrareembolso and Income/Bank Transfer minimum order will be 49€.
LETIPharma is a bio-pharmaceutical research company, independent and family capital.
In its different areas of expertise, seeks to provide society with products that add value to health care.
Its headquarters are in Barcelona and the industrial plant and the allergy research laboratory are in Tres Cantos (Madrid). It has subsidiaries in Germany (Ismaning and Witten) and in Portugal (Oporto). LETIPharma operates with exclusive distributors in various countries in Europe, Latin America and Africa.
Research and specialization are critical elements in the strategy of LETIPharma. Having innovative and patented products is essential to grow internationally in the chosen market segments. Therefore, LETIPharma has been devoting to research and product development between 10 and 20 percent of its turnover.
Internationalization is an essential element of our strategy. For a specialized company, penetrating foreign markets is a requirement to be able to grow, and this is facilitated by having our own products derived from research. Thus, for LETIPharma, internationalization is both a necessity and an opportunity, as well as being an important enriching element for your organization.
LETIPharma maintains a strategy of close and lasting collaborations with companies in the sector to boost its penetration in foreign markets and to expand its range of products. Also, with universities and research centers, for research and development projects, inside and outside of Spain.
LETIPharma is a founding member of Asebio (Spanish Association of Biocompanies) and of the EAMG (European Allergens Manufacturers Group), is a partner of Farmaindustria, of FENIN (Spanish Federation of Health Technology Companies) and of BPI (Bundesverband der Pharmazeutischen Industrie) and contributes to various organizations and non-profit foundations in areas related to health and education.
Leave us a message